Consumer medicine information

AmBisome 50 mg Powder for infusion

Amphotericin B (liposomal)

BRAND INFORMATION

Brand name

AmBisome

Active ingredient

Amphotericin B (liposomal)

Schedule

S4

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using AmBisome 50 mg Powder for infusion.

What is in this leaflet


This leaflet answers some common questions about AmBisome.
The medicine your doctor has prescribed for you is called AmBisome for Injection. This is the brand name of a drug called liposomal amphotericin B (amphotericin).
All medicines have risks and benefits. Your doctor has weighed the risks of you having AmBisome against the benefits it is expected to have for you.
If you have any concerns about having this medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine.
You may need to read it again.

What is AmBisome used for


AmBisome contains amphotericin B (amphotericin) which belongs to a group of medicines called antifungals.
It is used to help the body overcome serious fungal infections by either killing the fungus or stopping it spreading.
Amphotericin B (amphotericin) is also used to treat a disease which is rare in Australia called leishmaniasis.
Ask your doctor if you have any questions about why AmBisome has been prescribed for you.
Your doctor may have prescribed AmBisome for another reason.
AmBisome is not addictive.
This medicine is available only with a doctor’s prescription.

Before you are given AmBisome

When you must not have it:


Do not have AmBisome if you are allergic to:
  • amphotericin B (amphotericin) or
  • any of the other ingredients in AmBisome listed at the end of this leaflet.

Before you are given it


Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes. Tell your doctor if you have, or have had, any of the following medical conditions:
  • kidney disease
  • liver disease
  • diabetes

Tell your doctor if you are pregnant, or likely to become pregnant during your course of medication.
Your doctor can discuss with you the benefits and risks of having AmBisome.
Tell your doctor if you are breastfeeding, or likely to breastfeed during your course of medication.
AmBisome is not recommended during breastfeeding, as it may pass into breast milk.
If you have not told your doctor or pharmacist about any of the above, tell them before you are given AmBisome.

Taking other medicines


Tell your doctor or pharmacist if you are taking any other medicines including any that you buy without a prescription from your pharmacy, supermarket or health food shop.
Some medicines and AmBisome may interfere with each other. These include:
  • anticancer agents (chemotherapy)
  • digoxin (e.g. Lanoxin)
  • flucytosine (e.g. Ancotil)
  • cortisone-like medicine (e.g. hydrocortisone, betamethasone, dexamethasone, prednisolone, methylprednisolone)
  • corticotrophin (e.g. Acthargel)
  • dipyridamole (e.g. Persantin)

These medicines may be affected by AmBisome or may affect how well it works. You may need different amounts of the medicine, or you may need to take different medicines. Your doctor or pharmacist will advise you.

How AmBisome is given


AmBisome is to be administered only by or under the supervision of your doctor.
AmBisome must be reconstituted using Water for Injection and then filtered using a 5-micron filter into the correct amount of 5% Glucose Injection. It is given as a long running infusion (e.g. a slow injection via a “drip” into a vein).

If you have too much (overdose)


As AmBisome is most likely to be given to you in hospital under the supervision of your doctor, it is very unlikely that you will receive an overdose.
Severe side effects due to AmBisome are more likely to occur at high doses, particularly if you receive an overdose. Symptoms of AmBisome overdose include the side effects listed, but are usually of a more severe nature.
However, if you experience any severe side effects after being given AmBisome, tell your doctor immediately.

Side effects


Tell your doctor or pharmacist as soon as possible if you do not feel well while you are given AmBisome.
All medicines can have side effects. If they occur most are minor and temporary. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects. Do not be alarmed by these lists of possible side effects. You may not experience any of them.
Tell your doctor if you notice any of the following and they worry you:
Common side effects:

  • nausea and vomiting
  • rash
  • mild headaches

Less common side effects. The following side effects have been reported:
  • back pain
  • joint pain and bone pain
  • fever, chills
  • chest tightness
  • kidney problems
  • liver problems

Check with your doctor or pharmacist if you experience or do not understand any of the side effects described above.
Tell your doctor if you notice anything else that is making you feel unwell.
Other side effects not listed above may also occur in some people.

After receiving AmBisome

Storage


AmBisome should be stored in the pharmacy or on the hospital ward.
Keep out of reach of children.
Do not keep or use the medicine after the expiry date marked on the packet.
Unopened vials of AmBisome should be stored below 25°C.

Product Description

Ingredients


Each injection contains amphotericin equivalent to 50 mg of amphotericin B (amphotericin) plus hydrogenated soy phosphatidylcholine, cholesterol, distearoylphosphatidylglycerol (as the sodium salt), alpha tocopherol, sucrose and sodium succinate hexahydrate.

Manufacturer


AmBisome is supplied in Australia by:
Gilead Sciences Pty Ltd
Level 6, 417 St Kilda Road
Melbourne, Victoria 3004
AUST R 53783
AmBisome is supplied in New Zealand by:
Gilead Sciences (NZ)
c/- PricewaterhouseCoopers
Level 8 Pricewaterhousecoopers Tower
188 Quay Street
Auckland 1010
AmBisome® is a registered trademark licensed to Gilead Sciences Pty. Limited.
Date of Preparation: 30 March 2017

BRAND INFORMATION

Brand name

AmBisome

Active ingredient

Amphotericin B (liposomal)

Schedule

S4

 

1 Name of Medicine

AmBisome (liposomal amphotericin B).

2 Qualitative and Quantitative Composition

AmBisome is available in vials as powder for injection. Each vial contains amphotericin B equivalent to 50 mg of amphotericin B encapsulated in the bilayer of liposomes consisting of approximately 213 mg hydrogenated soy phosphatidylcholine, 52 mg cholesterol, 84 mg distearoylphosphatidylglycerol (as the sodium salt), 0.64 mg alpha-tocopherol together with 900 mg sucrose, and 27 mg sodium succinate hexahydrate.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

AmBisome is a sterile, lyophilised product for intravenous infusion.

4 Clinical Particulars

4.9 Overdose

For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).
Symptoms. There have been no reports of patients who have been given overdoses of AmBisome. The symptoms of overdosage are likely to be an extension of the adverse reactions to AmBisome.
Management. If overdosage should occur, cease administration immediately. Symptomatic supportive measures should be instituted. Carefully monitor clinical status including renal and hepatic function, serum electrolytes and haematologic status. Haemodialysis or peritoneal dialysis does not appear to affect the elimination of AmBisome.

5 Pharmacological Properties

5.3 Preclinical Safety Data

Carcinogenicity, genotoxicity and impairment of fertility. No long-term studies in animals have been performed to evaluate the carcinogenic potential of AmBisome or of conventional amphotericin B. There have been no studies to evaluate genotoxicity.

6 Pharmaceutical Particulars

6.7 Physicochemical Properties

Chemical structure. The chemical structure of amphotericin B (amphotericin) is shown below.
https://stagingapi.mims.com/au/public/v2/images/fullchemgif/CSAMPHOT.gif CAS number. 1397-89-3.

7 Medicine Schedule (Poisons Standard)

S4.

Summary Table of Changes

https://stagingapi.mims.com/au/public/v2/images/fulltablegif/AMBISOST.gif